Valuation GC Genome Corporation

Stocks

End-of-day quote Korea S.E. 02/09/2026			5-day change	1st Jan Change
5,630.00 ^KRW	-4.41%		+6.03%	-17.45%

12-09	GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy	CI
12/06/25	GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027
Market Cap ¹	161,298	133,154	-
Change	-	-17.45%	-
Enterprise Value (EV) ¹	161.3	73.75	64.35
Change	-	-54.27%	-12.75%
P/E	36.9x	-	-
PBR	-	-	-
PEG	-0x	-	-
Capitalization / Revenue	-	3.41x	2.73x
EV / Revenue	-	1.89x	1.32x
EV / EBITDA	-	-	-
EV / EBIT	-	18.4x	9.19x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ³	-	-	-
Rate of return	-	-	-
EPS ³	185	-	-
Distribution rate	-	-	-
Net sales ¹	-	39	48.8
EBITDA	-	-	-
EBIT ¹	-	4	7
Net income	4.044	-	-
Net Debt ¹	-	-59.4	-68.8
Reference price ³	6,820.00	5,630.00	5,630.00
Nbr of stocks (in thousands)	23,651	23,651	-
Announcement Date	16/03/26	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GC GENOME CORPORATION	-	2.05x	-	-	102M
NATERA, INC.	-234.01x	15.55x	-278.7x	-.--%	46.24B
LABCORP HOLDINGS INC.	23.51x	2.15x	12.15x	0.89%	26.57B
SONIC HEALTHCARE LIMITED	16.02x	1.26x	7.18x	5.47%	6.94B
RADNET, INC.	1078.86x	-	-	-	5.94B
DR. LAL PATHLABS LIMITED	51.51x	9.49x	32.7x	0.97%	3.35B
GENEDX HOLDINGS CORP.	-25.28x	-	-	-	2.53B
NEOGENOMICS, INC.	-58.45x	-	-	-.--%	2.24B
FLEURY S.A.	14.5x	1.47x	5.77x	5.25%	2.03B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	30.88x	1.63x	12.2x	1.46%	1.88B
Average	99.73x	4.80x	-34.78x	2.01%	9.78B
Weighted average by Cap.	-36.90x	9.45x	-142.15x	0.88%